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Neutrophil Gelatinase-Associated Lipocalin in Dogs With Sepsis
Undergoing Emergency Laparotomy: A Prospective Case–Control
Study
S. Cortellini, L. Pelligand, H. Syme, Y.M. Chang, and S. Adamantos
Background: Neutrophil gelatinase-associated lipocalin (NGAL) is an early indicator of acute kidney injury (AKI) in dogs
and its use has not been evaluated in dogs with sepsis.
Animals: Fifteen dogs with sepsis requiring laparotomy (study dogs) and 10 dogs undergoing surgery for intervertebral
disc disease (control dogs).
Objective: To determine whether NGAL increases in dogs with sepsis undergoing emergency laparotomy and whether it
is correlated with development of AKI and survival.
Methods: Longitudinal study conducted at a referral teaching hospital. Serum neutrophil gelatinase-associated lipocalin
(sNGAL), urinary NGAL normalized to urinary creatinine concentration (UNCR), and serum creatinine concentration were
measured at 4 time points (admission, after anesthesia, and 24 and 48 hours postsurgery). Development of AKI (increase in
serum creatinine concentration of 0.3 mg/dL) and in-hospital mortality were recorded. Linear mixed-model analysis was
employed to assess differences between groups over time. Mann–Whitney U-test was performed for comparison of continuous
variables between groups and Chi square or Fisher’s exact tests were used to assess correlation between discrete data.
Results: Serum NGAL and UNCR were significantly higher in study dogs across all time points (P = .007 and P < .001,
respectively) compared with controls. Urinary NGAL normalized to creatinine in the study group was not significantly differ-
ent between survivors (n = 12) and nonsurvivors (n = 3). Dogs that received hydroxyethyl starch had significantly higher
UNCR across all time points (P = .04) than those that did not.
Discussion—Conclusion: Serum neutrophil gelatinase-associated lipocalin and UNCR are increased in dogs with sepsis
requiring emergency laparotomy. Additional studies are needed to evaluate its role as a marker of AKI in this population.
Key words: Acute kidney injury; Canine; Neutrophil gelatinase-associated lipocalin.
Acute kidney injury (AKI) is defined as a suddeninjury to the renal parenchyma and reduction in
renal function, regardless of underlying cause.1 In criti-
cal illness and in sepsis, AKI has been identified as one
of the main contributors to morbidity and mortality in
human patients.2,3
The incidence of AKI in hospitalized septic dogs
managed in an intensive care setting has been reported
as 12% and the in-hospital mortality rate for dogs with
AKI varies from 54% to 86%.4,5
No consensus has yet been reached in veterinary
medicine, however, with regard to criteria that should
be used to define kidney injury. There are several
emerging classification systems available, including vet-
erinary AKI staging system (VAKI) and risk, injury,
failure, loss of kidney function, and end-stage kidney
disease-like criteria.4,6
The main pitfalls of the current systems are the use
of insensitive and poorly specific markers, such as
serum creatinine concentration or urine output. Serum
creatinine concentration is not linearly related to
glomerular filtration rate (GFR) and can be influenced
by factors other than renal function such as muscular
mass and hydration state.7 Glomerular filtration rate is
the gold standard for the diagnosis of renal disease, but
this method, aside from not being readily clinically
available, only detects reduction in renal function and
not cellular injury, thus, leading to delayed recognition
of disease.1,8
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Since the 1990s, there has been a perceived need to
identify early markers of AKI in order to identify
at-risk patients. To this end, many biomarkers, such as
N-acetyl-b-D-glucosaminidase, kidney injury molecule-1
(KIM-1), and neutrophil gelatinase-associated lipocalin
(NGAL) have been studied in human and canine
patients.7,8
Neutrophil gelatinase-associated lipocalin is a 25 kDa
protein, belonging to the lipocalin family. It is cova-
lently bound to gelatinase and secreted by neutrophils
and is normally expressed at low concentrations in the
kidney, lung, trachea, and gastrointestinal tract.9,10 It is
freely filtered through the glomerulus and re-absorbed
in the proximal tubule, such that healthy individuals
usually have very low urinary excretion of NGAL.11 Its
production is highly upregulated when epithelial cell
damage occurs. In clinical studies in people and dogs,
its concentration in urine increases 24–72 hours before
serum creatinine concentration, which enables earlier
detection of AKI.9,12,13 Neutrophil gelatinase-associated
lipocalin can be measured in plasma, serum or in urine
and it usually is expressed as an absolute concentration.
In some studies, urinary NGAL has been normalized to
urinary creatinine concentration in an attempt to
decrease variation associated with changes in urine
volume.12,14,15
Plasma and urine NGAL is increased in people with
sepsis and studies have shown an inconsistent ability for
plasma or serum NGAL to detect AKI in humans with
severe sepsis or septic shock.16,17
The ability of urinary NGAL to predict AKI recently
has been evaluated in veterinary medicine. A number of
clinical studies, published in the last few years, have
shown a significantly higher urinary NGAL concentra-
tion in dogs with AKI compared to healthy dogs.12–14
The aim of this study was to evaluate the usefulness
of both serum NGAL and urine NGAL normalized to
urinary creatinine (UNCR) for detecting AKI in dogs
with sepsis undergoing emergency laparotomy com-
pared to dogs with intervertebral disc disease undergo-
ing surgery. It was hypothesized that an increase in
urinary NGAL concentration would be associated with
the development of AKI, longer time to discharge,
increased morbidity (assessed by the acute patient phys-
iologic and laboratory evaluation score [APPLE] full
scoring system and multiple organ dysfunction
syndrome [MODS] criteria), and higher mortality.
Material and Methods
The study was a prospective investigation performed on client-
owned dogs. The protocol was approved by the Ethics and Wel-
fare Committee of the Royal Veterinary College, London (URN
2012 1155) and informed owner consent was obtained before
enrolling each dog in the study.
The study group included dogs with sepsis that were to undergo
emergency laparotomy. Dogs initially were recruited if they ful-
filled systemic inflammatory response syndrome (SIRS) criteria
(Table 1).18 Dogs were included in the analysis if they fulfilled cri-
teria for sepsis (ie, the presence of SIRS and confirmed or sus-
pected infection).19 Infection was defined as the presence of
intracellular bacteria on cytological examination or microbiologi-
cal evidence of infection in the abdominal fluid or aspirates from
an abscess. Dogs with azotemia (defined as plasma or serum crea-
tinine concentration >1.57 mg/dL [138 lmol/L]) on presentation,
or a history of chronic kidney disease, were excluded from the
study.
A control group of systemically healthy dogs undergoing emer-
gency surgical intervention for intervertebral disk disease (IVDD)
also was recruited.
Admission Data
Clinical data were collected on admission and included signal-
ment, disease process, heart rate, respiratory rate, rectal tempera-
ture, systolic blood pressure, whole blood lactate concentration,
and serum creatinine concentration.
Hospitalization Data
Before or during the course of hospitalization, administration
of vasopressors, hydroxyethyl starches, blood products, human
serum albumin, and potentially nephrotoxic drugs (eg, nons-
teroidal anti-inflammatory drugs [NSAID], angiotensin-converting
enzyme inhibitors) were recorded.
Occurrence of AKI, azotemia, hypotension, and survival were
recorded as categorical data. Acute kidney injury was defined as
an increase in serum creatinine concentration of 0.3 mg/dL
(26.4 lmol/L) within 48 hours, in keeping with the Acute kidney
injury network criteria.4 Serum creatinine concentration was mea-
sured on admission, postanesthesia and 24 and 48 hours post-
surgery. Hypotension was defined as a systolic Doppler pressure
<90 mmHg or a mean invasive arterial pressure <60 mmHg. The
APPLE full score on admission was calculated for each dog when
data were available.20 Multi-organ dysfunction syndrome was
defined as ≥2 organ systems having signs of dysfunction.5
Sampling and Sample Processing
Blood and urine samples were taken from dogs in both groups
for NGAL and creatinine measurements. Samples were taken at 4
time points: (I) on admission, (II) after anesthesia (within 2 hours
postanesthesia), and (III) 24 and (IV) 48 hours postoperatively.
Because ours was a clinical study performed in the United King-
dom on nonexperimental animals, only residual volumes of blood
taken from samples for clinical need could be used.
Urine samples were collected by voiding or from an indwelling
urinary catheter, and an aliquot of each fresh urine sample was
submitted to the laboratory for urinalysis (refractometric urine
specific gravity [USG], dipstick semiquantitative chemistry, and
sediment examination) and urine protein-to-creatinine ratio (UP:
C) measurement.a Pyuria was defined as ≥5 white blood cells per
high power field.21 Aliquots of the urine and serum samples were
centrifuged at 400 9 g for 5 minutes and the supernatant frozen
Table 1. Systemic inflammatory response syndrome
(SIRS) criteria used for inclusion of dogs within the
study group; SIRS was defined if patients fulfilled 2 or
more criteria.18
Variable SIRS criteria fulfilled if
Heart rate >120/min
Respiratory rate >20/min
Body temperature <38.1°C or >39.2°C
White blood cell count <6 9 103 or >16 9 103/lL
Increased band neutrophils
with normal neutrophil count
3%
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at 70°C within 1 hour (urine) and 8 hours (serum) for later
batch analysis.
Serum creatinine concentrations were determined from stored
frozen serum samples using a biochemical analyzer.a Serum
NGAL was measured on the same day using the same thawed
samples. All samples thawed for NGAL analysis were refrozen
within 1 hour to allow for re-analysis if required.
Urine and serum NGAL concentrations were determined using
a sandwich ELISA,b,c following the manufacturer’s instructions.d
Urine and serum samples initially were diluted 1 : 200 using the
diluent provided in the kit and the assay was performed according
to the manufacturer’s instructions. When necessary, dilution of the
samples was adjusted (1 : 20 to 1 : 10,000) to ensure that the
NGAL concentration fell on the linear part of the standard curve.
Samples requiring further dilution were thawed and frozen a maxi-
mum of 3 times. This thaw–refreeze process has been shown not
to affect NGAL stability.15 Urinary NGAL concentrations were
normalized by the urinary creatinine concentration (mg/dL) to
express results as UNCR. The final normalized urinary NGAL
(UNCR) is expressed as ng/mg.
A dual set of pooled quality control samples (high and low con-
centrations) also were included within each plate for assessment of
interassay and intra-assay variability.
Statistics
Statistical analyses were performed in SPSSe and figures were
drawn using Graphpad Prism.f Continuous data were presented as
median (range) in the original scale because some of the data have
been log-transformed in the statistical analysis and the sample size
was small.
Repeated measurement of UNCR and serum neutrophil gelati-
nase-associated lipocalin (sNGAL) were analyzed in a linear
mixed-effects model (LMM) taking time, group (sepsis versus con-
trol dogs), colloids, AKI, MODS, hypotension, and blood product
requirement as potential fixed effects and dog as random effect.
Potential 2-way interactions between categorical fixed factors and
time were assessed. A continuous variable was log-transformed if
its residuals from LMM analysis were skewed to the right.
Although many continuous data were normally distributed,
admission data between clinical course and treatment groups and
survivors were compared using the Mann–Whitney U-test because
of the small sample size. Similarly, Spearman’s correlation coeffi-
cient was used to measure the linear correlation between the 2 sets
of continuous data to avoid the potential influence of outliers. The
association between categorical variables was analyzed using chi-
squared or Fisher’s exact test if the contingency table contained a
value <5. Statistical significance was set at P < .05.
Results
Recruitment and Admission Characteristics
Twenty-one dogs were enrolled in the study group
and 10 dogs were enrolled in the control group between
June 2012 and August 2013. One dog in the study
group subsequently was excluded because no urine had
been stored for presurgery NGAL analysis. Twenty
dogs initially were included in the study. Five of these
were removed because they did not fulfill criteria for
sepsis. Four of these dogs had gastric dilatation and
volvulus and 1 had severe gastroenteritis. The final
study group therefore was represented by 15 dogs. Of
these dogs, 13 had septic peritonitis and 2 had intra-
abdominal abscessation.
Admission variables and days of hospitalization were
compared between the study and the control groups
and reported in Tables 2 and 3.
Clinical Course and Treatment
All dogs, in both the study and control groups, had
blood pressure recorded over the course of the entire
anesthetic period, and the study population had peri-
odic blood pressure measurements made during hospi-
talization (Tables 2 and 3). Eleven of 15 dogs in the
study group were hypotensive (4 pre-operatively and 10
intra-operatively). Two of 3 nonsurvivors were hypoten-
sive in the immediate postoperative period and required
vasopressor therapy. Blood pressure was not measured
on admission for any of the dogs in the control group
because they were considered to be cardiovascularly
stable based on clinical examination.
None of the dogs in the control group developed
AKI, whereas 2/15 (13%) dogs in the study group met
AKI criteria. but did not become azotemic (serum crea-
tinine concentration increased by 0.57 mg/dL [50 lmol/
L] and 0.65 mg/dL [57 lmol/L] in 24 hours). These 2
dogs later were euthanized because of clinical deteriora-
tion. No difference was identified between the incidence
of AKI in the study and control groups (P = .5;
Table 3).
In the study population, 12 dogs (80%) survived to
discharge, 1 dog died. and 2 were euthanized after clini-
cal deterioration. Nine dogs (90%) in the control group
were discharged, with 1 being euthanized because of
persistent paraplegia (Table 3).
Serum NGAL Results
Intra-assay and inter-assay variability for sNGAL
was 2.0% and 10.4% for the high concentration quality
control, and 7.7% and 19.3% for the low concentration
quality control, respectively.
No significant difference was identified for time-group
interaction and among times, but sNGAL was signifi-
cantly higher in the study population compared to the
control population (P = .007; Fig 1 and Table 4). A
time-colloid administration interaction was present
(P = .01). The cause of significance seemed to derive
mainly from the difference between the time points
within the noncolloid group, and there was no differ-
ence between the colloid group at all time points
(Table 4). There was no association between AKI,
MODS development, hypotension and survival, and
sNGAL (Table 4).
UNCR Results
There was no time-group interaction and no differ-
ence among times for UNCR, but the study group had
significantly higher UNCR than did the control dogs at
all measured time points (P < .001). No association was
detected between the UNCR and development of AKI
(P = .25) or MODS (P = .49; Fig 2 and Table 4). Four
of the 30 dogs (2 in each group) had pyuria. There was
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no association between UNCR and the presence of
pyuria at any of the time points (P = .55). None of the
dogs in the control group was diagnosed with a urinary
tract infection (UTI). One dog in the study group was
diagnosed with a UTI, and this dog also had prostatic
abscessation and septic peritonitis.
No time-colloids administration interaction was iden-
tified and no difference among time points was detected.
Dogs that received hydroxyethyl starchg (12/30), how-
ever, had significantly higher UNCR compared to dogs
that did not across all time points (P = .04; Fig 3 and
Table 4), with the 2 dogs that developed AKI receiving
colloids, either pre-operatively or intra-operatively.
All dogs in the control group received NSAIDs after
anesthesia, whereas none of the dogs in the study group
received NSAIDs after admission. No time-NSAID
administration interaction and no difference among
times was detected, but dogs in the study group that
did not receive NSAIDs before admission (n = 11) had
significantly higher UNCR (P = .04; Table 4).
There was a significant association between UNCR
and days spent in the intensive care unit (ICU;
Table 5), but no correlation was found between UNCR
and duration of hospitalization (admission, P = .5;
post-anesthesia, P = .3; 24 hours, P = .34; 48 hours,
P = .09).
No significant difference in UNCR was detected
between dogs that survived to discharge and those that
did not (P = .08).
Correlation
There was a moderate correlation between the
UNCR and sNGAL on admission (rs 0.76) and
postanesthesia (rs 0.82; Table 4). No correlation was
found between UNCR and urinary pH and USG.
There was a correlation between UNCR and UP:C
(admission, rs 0.61; postanesthesia, rs 0.92; 24 hours, rs
0.87; 48 hours, rs 0.75), but no correlation was found
Table 2. Measurements taken at admission between study and control patients.
Study Control P value
Heart rate (bpm) 128 (70–190) 120 (80–172) 1
Respiratory rate (rpm) 36 (20–100) 40 (20–80) .69
Temperature (°C) 39.2 (37.8–40.7) 38.8 (36.9–39.4) .36
White Blood cells (109) 17.3 (2.2–47.8) – –
Lactate (mg/dL) (R.I. 0–22.5) 11.7 (6.3–99) (n = 15) 16.2 (16.2–18) (n = 3) .2
Doppler systolic blood pressure (mmHg) 130 (60–170) – –
R.I., Reference Interval.
Measurements are expressed as median (range) and statistical significance was set at P < .05.
Table 3. Pre-admission treatment, clinical course and
treatment received in the study and in the control dogs.
Study Control
P
value
Admission characteristic
Previous surgery (5 days) 5/15 (33%) 0/10 (0%) .61
Fluid therapy prior
admission (crystalloids)
13/15 (86%) 1/10 (10%) <.01
Nonsteroidal
anti-inflammatory
medications
4/15 (27%) 6/10 (60%) .12
Clinical course
Hypotension 11/15 (73%) 0/10 (0%) <.01
APPLE score 28 (8–38)
(14/15)
– –
MODS 4/15 (27%) 0/10 (0%) .12
AKI 2/15 (13%) 0/10 (0%) .5
Survival to discharge 12/15 (80%) 9/10 (90%) .62
Treatment
Blood products 5/15 (33%) 0/10 (0%) .06
Human serum albumin 3/15 (20%) 0/10 (0%) .25
Hydroxyethyl
starch (Voluven)
9/15 (60%) 0/10 (0%) <.01
Days Hospitalization 7 (1–11) 12.5 (1–11) .42
Days ICU 3 (1–11) 0 (0–0) <.01
APPLE score was calculated.20 MODS (Multi-Organ Dysfunc-
tion Syndrome) was defined as dysfunction of at least 2 organs.5
AKI (Acute Kidney Injury) was defined as an increase of 0.3 mg/
dL (26.5 lmol/L) from baseline.4
Significant differences are highlighted (bold; significance set at a
P value ≤.05).
Fig 1. The medians and interquartile range of serum neutrophil
gelatinase-associated lipocalin at different times between the con-
trol and the study group are represented by the bar and the whis-
kers with all the patients displayed in a scattered plot manner. The
2 acute kidney injury patients are represented by x and ♦ on the
graph. Serum neutrophil gelatinase-associated lipocalin concentra-
tions were significantly higher across all time points in the study
group.
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between UNCR and APPLE full score at any of the
time points (Table 4).
Discussion
Our study focused on detecting the effect of sepsis
on sNGAL and UNCR and to assess their changes
over the course of hospitalization. The control popula-
tion was chosen to compare the effect of general anes-
thesia and surgery on NGAL in comparison to the
septic dogs undergoing emergency laparotomy. This
group was also chosen because it theoretically allowed
timed and noninvasive urine sampling because of the
routine placement of urinary catheters or bladder
expression.
Sepsis has been shown to be associated with devel-
opment of AKI secondary to ischemia-reperfusion
injury, damage induced by pro-inflammatory cytokines
and oxidative stress and tubular dysfunction leading to
decreased glomerular filtration and tubular reabsorb-
tion dysregulation.22 Neutrophil gelatinase-associated
lipocalin is secreted by neutrophils and it is therefore
logical to expect an increase in its concentration in
inflammatory states. In particular, during sepsis,
NGAL expression increases, not only in the kidney
but also in leukocytes and liver. Therefore, higher
Table 4. Differences in sNGAL and UNCR for each
single category and differences between time and time-
category interaction.
Category Category Time
Time-category
interaction
sNGAL Sepsis P = .007 P = .13 P = .95
AKI P = .28 P = .24 P = .83
Hypotension P = .49 P = .23 P = .33
Survival P = .09 P = .25 P = .34
NSAIDs P = .12 P = .23 P = .47
Colloids P = .72 P = .16 P = .01
MODS P = .49 P = .24 P = .57
Blood products P = .96 P = .24 P = .43
UNCR Sepsis P < .001 P = .29 P = .12
AKI P = .25 P = .1 P = .5
Hypotension P = .55 P = .08 P = .75
Survival P = .08 P = .11 P = .19
NSAIDs P = .04 P = .08 P = .21
Colloids P = .04 P = .12 P = .07
MODS P = .49 P = .08 P = .44
Blood products P = .21 P = .1 P = .07
AKI, acute kidney injury; NSAID, nonsteroidal anti-inflamma-
tory drug; MODS, Multi-organ dysfunction syndrome; UNCR,
urinary NGAL normalized to creatinine.
Significant differences are highlighted (bold; significance set at a
P value < .05)
Fig 2. The medians and interquartile ranges of urinary neutrophil gelatinase-associated lipocalin to creatinine ratio (UNCR) at different
times between the control and the study group are expressed by the bar and the whiskers, respectively, with the single patients displayed in
a scatter plot manner. The 2 patients with acute kidney injury have been identified with x and ♦. The study group had significantly higher
UNCR across all the time points (P < .001).
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NGAL both in blood and in urine are expected,
regardless of AKI.11 A study in human patients
showed that sNGAL was increased in patients with
sepsis, severe sepsis, and septic shock, but was not able
to detect AKI in this population, especially in the
sicker categories.16 The results of the present study
confirm that sNGAL was also increased in dogs with
sepsis compared to a control population. However,
sNGAL was not associated with mortality or corre-
lated with the severity of the disease, as assessed by
the APPLE scoring system or MODS development,
suggesting that this marker may not be a useful clini-
cal severity predictor.
The UNCR differed between the study and control
groups across all time points was evaluated (P < .001).
The median UNCR concentration in the study group
postanesthesia was as high as 114 times (admission) and
185 times higher than in the control group, highlighting
the marked difference between the 2 groups. However,
similar to sNGAL, UNCR was not associated with
mortality, suggesting that this marker may not be useful
to assess the severity of disease.
A study in people showed that septic AKI patients
had higher urinary NGAL than nonseptic AKI
patients.23 Both sNGAL and UNCR were not associ-
ated with AKI development over the course of hospital-
ization in this study. This finding may be a consequence
of the inability of NGAL to distinguish between the
presence of AKI and systemic inflammation in septic
dogs, and as a result may suggest that NGAL is a poor
marker of AKI in this population of dogs. The lack of
significance to detect AKI, however, could have been a
result of the small population size and thus indicate a
type II error.
Neutrophil gelatinase-associated lipocalin increases
3 hours after ischemic renal injury in people undergoing
cardio-pulmonary bypass and peaks at 36 hours in criti-
cally ill patients developing AKI during hospitaliza-
tion.24 However, NGAL has been shown to increase up
to 72 hours earlier than serum creatinine concentration
in the event of AKI. Therefore, this study may not have
detected an increase in serum creatinine concentration if
it occurred after the 48 hours in sample, potentially
leading to AKI recognition being missed in some
patients.10,23 This time window was selected based on
evidence in human patients showing that adverse out-
come is associated with increased serum creatinine con-
centration within 48 hours, and the immediate
postoperative period was deemed most appropriate to
detect eventual development of AKI.13,25
The increase in UNCR in dogs with sepsis in our
study perhaps represents sub-clinical AKI, not detected
by the VAKI system, or may have been related to an
increase in serum creatinine concentrations that
occurred after 48 hours.4 The increase in serum crea-
tinine concentration used to define AKI in our study
was considered to be a sensitive way of identifying these
dogs. However, serum creatinine concentration may not
be altered in the event of tubular injury, indicated by
an increase in NGAL production, because the GFR of
Fig 3. The medians and interquartile ranges of urinary neutrophil
gelatinase-associated lipocalin to creatinine ratio (UNCR) at dif-
ferent times between patients that received colloids and patients
that did not are expressed by the bar and the whiskers, respec-
tively, with the single patients displayed in a scatter plot manner.
Statistical significance was set at P < .05. Dogs that received col-
loids had significantly higher UNCR concentration across all time
points.
Table 5. Spearman’s correlation (rs) between UNCR and UP:C, serum creatinine, sNGAL, day in ICU and APPLE
score.
UP:C Serum creatinine sNGAL Days ICU APPLE score
UNCR admission UP:Cadm
P < .001; rs 0.61
Creatadm
P = .17
sNGALadm
P < .01; rs 0.76
P < .001; rs 0.7 P = .44
UNCR post UP:Cpost
P < .001; rs 0.92
Creat.post
P = .03; rs 0.54
sNGAL.post
P < .01; rs 0.82
P < .001; rs 0.77 P = .71
UNCR 24 UP:C24
P < .001; rs 0.87
Creat.24
P = .11
sNGAL24
P = .07
P < .001; rs 0.79 P = .08
UNCR 48 UP:C48
P = .001; rs 0.75
Creat.48
P = .15
sNGAL.48
P = .33
P < .001; rs 0.77 P = .2
sNGAL, serum neutrophil gelatinase-associated lipocalin; APPLE, acute patient physiologic and laboratory evaluation score; UNCR,
urinary NGAL normalized to creatinine.
Statistical significance was set at P < .05.
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the affected nephrons may not be altered or overall
renal compensation may occur in other nephrons. Con-
versely, tubular injury, detected by an increase in
NGAL concentration, may lead to a decrease in
glomerular function as a consequence of tubular flow
obstruction and tubulo-glomerular interaction.26 In this
situation, NGAL may not be correlated with GFR, and
its increase does not consistently reflect a change in
serum creatinine concentration.
It is unlikely that the difference in UNCR between
the 2 groups was a consequence of altered passage of
NGAL across the glomerular filtration barrier. In fact,
although there was an association between UP:C and
UNCR, sNGAL, and UNCR were only moderately
correlated on admission and post anesthesia. It appears
more likely that in severe inflammation, renal derange-
ments lead to decreased re-absorptive capacity in the
proximal tubules or upregulation of NGAL production
at the level of the thick ascending loop, distal tubule,
and collecting ducts.10
One study showed that, in dogs undergoing surgery,
urinary NGAL was significantly higher in dogs with
AKI 12 hours postoperatively, whereas plasma NGAL
was not able to detect AKI.13 Another study in dogs
with a variety of diseases, including heatstroke and
snake envenomation, showed that UNCR on admission
was significantly higher in dogs with AKI (grade I to
V) and detected AKI earlier than the increase in
plasma creatinine concentration.12 However, 9 of 15
dogs (60%) in our study had UNCR results on admis-
sion higher than the cutoff of 238 ng/mg established by
a previous study for distinguishing nonazotemic AKI
grade I patients from dogs with related renal or uri-
nary conditions.12 However, the pathophysiology of
AKI in sepsis is substantially different from other
causes of AKI, such as ischemia or toxic damage, and
NGAL expression is upregulated in inflammatory con-
ditions, such as infection.21,22 Of the 9 dogs with
UNCR >238 ng/mg, only 2 developed AKI and
none of them developed azotemia. This cutoff may
therefore not be useful in dogs with sepsis and
additional studies are needed to establish a cutoff for
this population.
Both UNCR and sNGAL were not significantly asso-
ciated with time to discharge, but were associated with
ICU stay. Timing of discharge and ICU hospitalization
are clinician-dependent and financially based decisions
and these factors might have influenced this result. In
addition, our control population was represented by
patients with IVDD, which have predictably long hospi-
talization times.
Patients that did not receive NSAIDs before admis-
sion had higher UNCR compared to patients that did
across all time points. This difference may have been
simply a consequence of more severe disease in dogs
not receiving NSAIDs, because there currently is no evi-
dence that NSAIDs may induce urinary NGAL down-
regulation.
An interesting finding was the significant difference
in UNCR between the dogs that received colloids and
dogs that did not. The higher UNCR in dogs that
received colloids was consistent across all 4 time
points, and UNCR was increased before surgery
although only 4 of the 9 dogs were given colloids on
admission, whereas 4 received them intra-operatively
and 1 postoperatively. This difference may simply
reflect a difference in severity of illness, because col-
loids typically are used more often in dogs with more
serious signs of hypoperfusion and potentially more
severe inflammation. This may have induced an upreg-
ulation of NGAL secretion and an increase in UNCR
independent of colloid administration.11
In people, hydroxyethyl starches are associated with
an increased risk of kidney injury, and recent studies
have highlighted an association between the use of
hydroxyethyl starches (including pentastarch and tetra-
starch) and kidney injury or renal replacement therapy
requirement.27,28 Usually, an increase in uNGAL is
expected to occur at least 3 hours after the renal
injury.11 If these artificial colloids induced AKI in the
dogs of our study, a difference at the pre-anesthesia
sample would not be expected, because most patients
did not receive hydroxyethyl starches until intra-opera-
tively or postoperatively. The results of our study
should therefore be interpreted with caution.
One limitation of this study is that there were 21/100
urine samples and 40/100 serum samples missing. Anal-
ysis of all of the samples may have added further infor-
mation to our analysis and allowed better interpretation
of the data. The absence of results, in addition to the
small number of cases enrolled, therefore may have
caused the analysis to be underpowered.
A second limitation involves the choice of the con-
trol group. The median admission data for this group
was not significantly different from that of the study
group, leading to a potential confounding overlap
within the population (Tables 1 and 2). However, the
underlying diseases affecting the 2 groups were sub-
stantially different, being localized in the control dogs
and systemic and pro-inflammatory in the study
patients. Additional studies may benefit from the use
of more stringent SIRS criteria, allowing clear clinical
distinction between the control and the study group on
admission.
In addition, our study monitored serum creatinine
concentration for a 48-hour period. Because NGAL
may increase up to 72 hours earlier than the serum cre-
atinine concentration in the event of renal injury, some
patients with AKI may have been missed.11,24
A further limitation includes the clinician-based deci-
sion for administration of hydroxyethyl starches, blood
products or institution of vasopressor therapy, render-
ing objective interpretation of these data or assessment
of the severity of illness difficult. It is also currently
unknown whether drugs, such as human serum albu-
min, may affect serum and urinary NGAL release and
tubular re-absorption, interfering with the results of the
study.
Additional prospective studies with larger populations
of dogs with sepsis and use of additional urinary mark-
ers are warranted to assess the association between
NGAL and inflammation, sepsis and AKI.
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Footnotes
a IL600, Instrumentation Laboratory, Cheshire, UK
b Dog NGAL ELISA kit, BioPorto Diagnostics, Gentofte,
Denmark
c Tecan Sunrise Elisa-reader; Tecan Group Ltd., M€annedorf,
Switzerland
d http://ngal.com/media/35431/kit_043_quick_guide.pdf
e SPSS version 20, Chicago, IL
f Graphpad Prism, version 6, La Jolla, CA
g Voluven (6% Hydroxyethyl Starch 130/0.4 in 0.9% Sodium
Chloride), Fresenius Kabi Norge A.S., Halden, Norway
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